SRx Health Solutions receives notice from NYSE American, must regain compliance by July 14, 2026.
ByAinvest
Friday, Oct 17, 2025 8:05 am ET1min read
SRXH--
The company has been given until November 13, 2025, to submit a plan detailing the actions it will take to regain compliance with the Exchange's continued listing standards by the Plan Period Deadline of July 14, 2026. The receipt of the notice has no immediate effect on the listing or trading of SRx Health's common stock on the Exchange, nor does it impact the company's business operations or reporting requirements with the U.S. Securities and Exchange Commission.
Forward-looking statements included in the press release highlight the company's current expectations and projections about future events and financial trends. However, it is important to note that some or all of the results anticipated by these forward-looking statements may not be achieved.
SRx Health Solutions, Inc. has until November 13, 2025, to submit a plan of action to address the compliance issue. The company's Chief Executive Officer, Kent Cunningham, and Investor Contact, Valter Pinto, are available for further information.
• SRx Health Solutions received notice from NYSE American LLC for non-compliance.
• Company must have $4 million in stockholders' equity by July 2026.
• SRx Health has until November 13, 2025, to submit a plan of action.
• Receipt of notice has no immediate effect on listing or trading.
SRx Health Solutions, Inc. (NYSE American: SRXH) has received a notice from NYSE American LLC indicating that the company is not in compliance with the exchange's continued listing standards under Section 1003(a)(ii) of the NYSE American Company Guide, according to a GlobeNewswire release https://www.globenewswire.com/news-release/2025/10/17/3168585/0/en/SRx-Health-Solutions-Received-NYSE-American-Notification-Letter-Regarding-Stockholders-Equity-Deficiency.html. The notice, detailed in the notification letter https://www.stocktitan.net/news/SRXH/s-rx-health-solutions-received-nyse-american-notification-letter-u2lwu0ml57xt.html, was received on October 17, 2025, and specifies that the company must have stockholders' equity of $4 million or more if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years.The company has been given until November 13, 2025, to submit a plan detailing the actions it will take to regain compliance with the Exchange's continued listing standards by the Plan Period Deadline of July 14, 2026. The receipt of the notice has no immediate effect on the listing or trading of SRx Health's common stock on the Exchange, nor does it impact the company's business operations or reporting requirements with the U.S. Securities and Exchange Commission.
Forward-looking statements included in the press release highlight the company's current expectations and projections about future events and financial trends. However, it is important to note that some or all of the results anticipated by these forward-looking statements may not be achieved.
SRx Health Solutions, Inc. has until November 13, 2025, to submit a plan of action to address the compliance issue. The company's Chief Executive Officer, Kent Cunningham, and Investor Contact, Valter Pinto, are available for further information.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet